BioResearch took part in and won a tender for new, innovative clinical study with esketamine, sponsored by Celon Pharma S.A. Due to our experience, engagement and professional approach, our offer was the most attractive and well-prepared.

The study will begin in December, the clinical part will be conducted in our Site in Kajetany.